Cargando…
The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma
Cutaneous T‐cell lymphomas (CTCLs) have a chronic, relapsing course, and the most common subtypes are mycosis fungoides and Sézary syndrome. The disease causes visible skin alterations and can also cause alopecia, pruritus and pain, all of which can impact patients’ health‐related quality of life (H...
Autores principales: | Scarisbrick, Julia J., Bagot, Martine, Ortiz‐Romero, Pablo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894136/ https://www.ncbi.nlm.nih.gov/pubmed/33095448 http://dx.doi.org/10.1111/bjh.17117 |
Ejemplares similares
-
New Targeted Treatments for Cutaneous T-cell Lymphomas
por: Bagot, Martine
Publicado: (2017) -
The importance of assessing blood tumour burden in cutaneous T‐cell lymphoma
por: Vermeer, M.H., et al.
Publicado: (2021) -
Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial
por: Horwitz, Steven, et al.
Publicado: (2021) -
Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach
por: Vermeer, Maarten H., et al.
Publicado: (2022) -
Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study()()
por: Ogunsanya, M.E., et al.
Publicado: (2018)